Volume 9, Issue 3
Editorialp. 233
Steps in unraveling the mystery of chronic inflammation: TL1A
Author(s): K Reichwald & S Skov
News and Viewsp. 241
Roche receives EU approval for new subcutaneous formulation of RoACTEMRA
Author(s): News
News and Viewsp. 241
New clues on tissue scarring in scleroderma
Author(s): News
News and Viewsp. 241
Sprifermin may offer benefit for cartilage loss in knee osteoarthritis
Author(s): News
News and Viewsp. 241
Study identifies potential molecules involved in rheumatoid arthritis angiogenesis
Author(s): News
Conceptual Paperp. 245
Role of golimumab for the treatment of rheumatoid arthritis
Author(s): G Tran & P Emery
Conceptual Paperp. 259
Potential role of apremilast for the treatment of psoriatic arthritis
Author(s): A Souto & JJ Gómez-Reino
Research Articlep. 267
Comparing different preparations and doses of rosehip powder in patients with osteoarthritis of the knee: an exploratory randomized active-controlled trial
Author(s): R Christensen, S Tarp, RD Altman, M Henriksen, EM Bartels, L Klokker, M Boesen, DE Furst, CC Holm, B Danneskiold-Samsøe & H Bliddal
Review Articlep. 279
Variability in clinical and biological response to rituximab in autoimmune diseases: an opportunity for personalized therapy?
Author(s): V Reddy & M Leandro
Review Articlep. 295
The lung may play a role in the pathogenesis of rheumatoid arthritis
Author(s): M Demoruelle, JJ Solomon, A Fischer & KD Deane
Review Articlep. 311
Glucocorticoid-induced osteoporosis: an overview
Author(s): NO Kuchuk, JN Hoes, JWJ Bijlsma & JWG Jacobs
Review Articlep. 327
Clinical measurement of disease activity in rheumatoid arthritis: why, how and utility of patient self-assessment
Author(s): PP Cheung & L Gossec
